… the vessel occluded RVO is classified in Central Retinal Vein Occlusion (… Retinal Vein
Occlusion (HRVO), where the occlusion involves one of the dual trunks of the central retinal vein …

… agents, there has been a paradigm shift in the treatment of RVO. Most importantly, there has
… the use of anti-VEGF in patients with retinal vein occlusions. Vascular endothelial growth …

… This meta-analysis analyses the efficacy and safety of anti-VEGF therapy for the treatment
of macular oedema secondary to BRVO. A total of 22 clinical studies were included in the …

… Eyes with retinal vein occlusion and 8-year follow-up data Of the 221 eyes that started
anti-VEGF therapy, 94 (43%) were still receiving anti-VEGF treatment at the same centre 8-years …

… Retinal vein occlusions (RVO) are the second most frequent retinal vasculopathy after diabetic
retinopathy. Retinal vein occlusions have a global age- and sex-standardized prevalence …

… In addition, while all patients in this analysis received anti-VEGF therapy, a minority of
patient eyes also underwent focal laser and panretinal laser or intravitreal corticosteroids, as …

… In summary, our findings show that anti-VEGF treatment in patients with RVO may have
beneficial long-term effects with good functional and anatomical outcomes for patients. Patients …

… in CRVO complicated by macular oedema improves following anti-VEGF treatment but real-…
Neovascularisation following CRVO can be substantially delayed by anti-VEGF treatment …

… : Anti-VEGF therapy may have a role in the treatment of macular oedema caused by central
retinal vein occlusions. … We would like to point out that the main use of anti-VEGF therapy in …

… confirmed that anti-VEGF treatment of RVO-associated macular edema is … treatment was
reported, and there were no reports of thromboembolic events related to anti-VEGF treatment…